DK0929270T3 - Orale farmaceutiske produkter med peptider - Google Patents

Orale farmaceutiske produkter med peptider

Info

Publication number
DK0929270T3
DK0929270T3 DK97915071T DK97915071T DK0929270T3 DK 0929270 T3 DK0929270 T3 DK 0929270T3 DK 97915071 T DK97915071 T DK 97915071T DK 97915071 T DK97915071 T DK 97915071T DK 0929270 T3 DK0929270 T3 DK 0929270T3
Authority
DK
Denmark
Prior art keywords
peptides
pharmaceutical products
oral pharmaceutical
oral
products
Prior art date
Application number
DK97915071T
Other languages
English (en)
Inventor
William Stern
James P Gilligan
Original Assignee
Unigene Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigene Lab Inc filed Critical Unigene Lab Inc
Priority claimed from PCT/US1997/004024 external-priority patent/WO1997033531A1/en
Application granted granted Critical
Publication of DK0929270T3 publication Critical patent/DK0929270T3/da

Links

DK97915071T 1997-03-14 1997-03-14 Orale farmaceutiske produkter med peptider DK0929270T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/004024 WO1997033531A1 (en) 1996-03-15 1997-03-14 Oral peptide pharmaceutical products

Publications (1)

Publication Number Publication Date
DK0929270T3 true DK0929270T3 (da) 2005-03-21

Family

ID=34311755

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97915071T DK0929270T3 (da) 1997-03-14 1997-03-14 Orale farmaceutiske produkter med peptider

Country Status (1)

Country Link
DK (1) DK0929270T3 (da)

Similar Documents

Publication Publication Date Title
ID24654A (id) Formulasi farmasi omeprazola
BR9611367A (pt) Formulação farmacêutic liofilizada estável
DE69525148D1 (de) Pharmazeutische formulierung
NO20001776L (no) Medikamenter
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
NO20003218D0 (no) Oralfarmasøytisk doseringsform med forlenget frigivningsvirkning
NO971422D0 (no) Medikamenter
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
DE59712959D1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
NO981008D0 (no) Farmasöytisk formulering
NO20020531D0 (no) Beta-carbolin medikament produkter
DK1017392T3 (da) Lægemiddel
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
DE69820861D1 (de) Teilchenförmige arzneimittelträger
ID16781A (id) Formulasi-formulasi farmasi
NO994619D0 (no) Farmasöytiske blandinger
ITMI941169A0 (it) Formulazioni farmaceutiche
ID30032A (id) Formulasi farmasi
NO20003141D0 (no) Farmasøytiske blandinger
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
FI973230A (fi) Uusi farmaseuttinen formulaatio
FI951155A0 (fi) Farmaseuttinen valmiste
DK0929270T3 (da) Orale farmaceutiske produkter med peptider